Industries
Oncology Diagnostics
Oncology diagnostics develops blood-based and genomic tests to detect and monitor cancer earlier and more precisely. It recruits molecular biologists and bioinformaticians from academia and partners with cancer centers on biomarker and assay research.
Details
- Companies
- GrailGuardant HealthFoundation MedicineExact SciencesNateraTempusFreenomeAdaptive BiotechnologiesCaris Life SciencesDelfi Diagnostics
- Market Size
- $55B
- Target Researchers
- Molecular biologists and bioinformaticians in liquid biopsy, NGS, methylation analysis, and assay development
- Use Cases
- Liquid-biopsy R&D recruitmentctDNA-assay validation partnershipsUniversity cancer-genomics collaborationsBioinformatics talent pipelineEarly-detection clinical-study alliances